140 related articles for article (PubMed ID: 15633140)
1. Suppression of FGF signaling: a putative mechanism for the chemopreventive effects of acyclic retinoid in hepatocellular carcinoma.
Wang L; Levin MS
Gastroenterology; 2005 Jan; 128(1):228-31. PubMed ID: 15633140
[No Abstract] [Full Text] [Related]
2. [Chemoprevention of hepatocellular carcinoma by acyclic retinoid].
Nagaki M; Shimizu M; Moriwaki H
Nihon Shokakibyo Gakkai Zasshi; 2008 Jun; 105(6):802-7. PubMed ID: 18525185
[No Abstract] [Full Text] [Related]
3. Apoptosis induction by acyclic retinoid: a molecular basis of 'clonal deletion' therapy for hepatocellular carcinoma.
Okuno M; Sano T; Matsushima-Nishiwaki R; Adachi S; Akita K; Okano Y; Kojima S; Moriwaki H
Jpn J Clin Oncol; 2001 Aug; 31(8):359-62. PubMed ID: 11574627
[TBL] [Abstract][Full Text] [Related]
4. Deletion of serum lectin-reactive alpha-fetoprotein by acyclic retinoid: a potent biomarker in the chemoprevention of second primary hepatoma.
Moriwaki H; Yasuda I; Shiratori Y; Uematsu T; Okuno M; Muto Y
Clin Cancer Res; 1997 May; 3(5):727-31. PubMed ID: 9815742
[TBL] [Abstract][Full Text] [Related]
5. Acyclic retinoid inhibits human hepatoma cell growth by suppressing fibroblast growth factor-mediated signaling pathways.
Shao RX; Otsuka M; Kato N; Taniguchi H; Hoshida Y; Moriyama M; Kawabe T; Omata M
Gastroenterology; 2005 Jan; 128(1):86-95. PubMed ID: 15633126
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of hepatocellular carcinoma: concept, progress and perspectives.
Okuno M; Kojima S; Moriwaki H
J Gastroenterol Hepatol; 2001 Dec; 16(12):1329-35. PubMed ID: 11851828
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of hepatocellular carcinoma by acyclic retinoid.
Shimizu M; Sakai H; Moriwaki H
Front Biosci (Landmark Ed); 2011 Jan; 16(2):759-69. PubMed ID: 21196201
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical and nutraceutical approaches for preventing liver carcinogenesis: chemoprevention of hepatocellular carcinoma using acyclic retinoid and branched-chain amino acids.
Shimizu M; Shirakami Y; Hanai T; Imai K; Suetsugu A; Takai K; Shiraki M; Moriwaki H
Mol Nutr Food Res; 2014 Jan; 58(1):124-35. PubMed ID: 24273224
[TBL] [Abstract][Full Text] [Related]
9. Current strategies for chemoprevention of hepatocellular carcinoma.
Okita K; Sakaida I; Hino K
Oncology; 2002; 62 Suppl 1():24-8. PubMed ID: 11868781
[TBL] [Abstract][Full Text] [Related]
10. Strategy and mechanism for the prevention of hepatocellular carcinoma: phosphorylated retinoid X receptor alpha is a critical target for hepatocellular carcinoma chemoprevention.
Shimizu M; Takai K; Moriwaki H
Cancer Sci; 2009 Mar; 100(3):369-74. PubMed ID: 19068086
[TBL] [Abstract][Full Text] [Related]
11. Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. Updated analysis of the long-term follow-up data.
Takai K; Okuno M; Yasuda I; Matsushima-Nishiwaki R; Uematsu T; Tsurumi H; Shiratori Y; Muto Y; Moriwaki H
Intervirology; 2005; 48(1):39-45. PubMed ID: 15785088
[TBL] [Abstract][Full Text] [Related]
12. Prevention of liver cancer: current strategies and future perspectives.
Moriwaki H
Int J Clin Oncol; 2002 Feb; 7(1):27-31. PubMed ID: 11942046
[No Abstract] [Full Text] [Related]
13. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma.
Muto Y; Moriwaki H; Shiratori Y
Digestion; 1998 Jul; 59 Suppl 2():89-91. PubMed ID: 9718434
[No Abstract] [Full Text] [Related]
14. Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma.
Muto Y; Moriwaki H; Saito A
N Engl J Med; 1999 Apr; 340(13):1046-7. PubMed ID: 10189289
[No Abstract] [Full Text] [Related]
15. Role of acyclic retinoid in the chemoprevention of hepatocellular carcinoma: basic aspects, clinical applications, and future prospects.
Shimizu M; Imai K; Takai K; Moriwaki H
Curr Cancer Drug Targets; 2012 Nov; 12(9):1119-28. PubMed ID: 22873214
[TBL] [Abstract][Full Text] [Related]
16. Can a vitamin prevent hepatocellular carcinoma?
Venook AP
Hepatology; 1997 Jan; 25(1):249-50. PubMed ID: 8985300
[No Abstract] [Full Text] [Related]
17. Peretinoin, an Acyclic Retinoid, for the Secondary Prevention of Hepatocellular Carcinoma.
Woo HY; Yoo SY; Heo J
Molecules; 2021 Jan; 26(2):. PubMed ID: 33435572
[TBL] [Abstract][Full Text] [Related]
18. Prevention of hepatocellular carcinoma by targeting MYCN-positive liver cancer stem cells with acyclic retinoid.
Qin XY; Suzuki H; Honda M; Okada H; Kaneko S; Inoue I; Ebisui E; Hashimoto K; Carninci P; Kanki K; Tatsukawa H; Ishibashi N; Masaki T; Matsuura T; Kagechika H; Toriguchi K; Hatano E; Shirakami Y; Shiota G; Shimizu M; Moriwaki H; Kojima S
Proc Natl Acad Sci U S A; 2018 May; 115(19):4969-4974. PubMed ID: 29686061
[TBL] [Abstract][Full Text] [Related]
19. [Adjuvant therapy after treatment of hepatocellular carcinoma].
Kasai K; Kuroda H; Suzuki K
Nihon Shokakibyo Gakkai Zasshi; 2008 Jun; 105(6):787-94. PubMed ID: 18525183
[No Abstract] [Full Text] [Related]
20. Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents.
Sakai H; Shirakami Y; Shimizu M
World J Gastroenterol; 2016 Jan; 22(1):394-406. PubMed ID: 26755885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
